Source: Annual Congress 2009 - EU Research Programmes. IMI: 1. U-BIOPRED asthma 2. PROactive COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. J. Sterk (Amsterdam, The Netherlands). U-BIOPRED: Towards phenotype handprints of severe asthma. Annual Congress 2009 - EU Research Programmes. IMI: 1. U-BIOPRED asthma 2. PROactive COPD

Member's Comments

No comment yet.

Related content which might interest you: Evolution from mild to severe asthma; the severe asthma clinic perspective Source: International Congress 2019 – Clinical implications of asthma management Year: 2019 Clinical phenotypes of severe asthma: children Source: Eur Respir Monogr 2019; 84: 64-81 Year: 2019 Only severe asthma? Source: International Congress 2019 – PG11 Severe paediatric asthma Year: 2019 Developing integrated handprints of severe asthma: the U-BIOPRED approach Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Difficult-to-treat asthma: how serious is the problem and what are the issues? Source: Eur Respir Mon 2011; 51: 1-15 Year: 2011 An invisible disease: severe asthma is more than just “bad asthma” Source: Eur Respir J, 50 (3) 1701109; 10.1183/13993003.01109-2017 Year: 2017 Treatment of severe childhood asthma: what’s the evidence? Source: Annual Congress 2005 - Difficult asthma in children Year: 2005 Clinical phenotypes of severe asthma: adults Source: Eur Respir Monogr 2019; 84: 48-63 Year: 2019 One year following a real life experience of omalizumab for moderate to severe persistent allergic asthma in Malta Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Safety of sputum monitoring in a severe asthma population - The Manchester severe asthma team experience Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Patients with allergic and eosinophilic asthma in the German severe asthma registry Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011 A different disease, many diseases or mild asthma gone bad? Challenges of severe asthma Source: Eur Respir J 2003; 22: 397-398 Year: 2003 The ERS/EAACI statement on severe exacerbations of asthma, and how to deal with non-allergic severe asthma Source: International Congress 2019 – Pathophysiology and clinical insights into severe non-allergic asthma Year: 2019 Early- and late-onsets of severe asthma are associated with divergent phenotypes of the disease Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Severe asthma: the way forward Source: Eur Respir Mon 2011; 51: 297-308 Year: 2011 Wet cough in paediatric severe therapy resistant asthma (STRA) Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques Year: 2016 The German severe asthma register Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases Year: 2012 Problematic severe asthma in children, not one problem but many: a GA2LEN initiative Source: Eur Respir J 2010; 36: 196-201 Year: 2010 Omalizumab in severe allergic asthma: a 4-year real world experience, Fife, Scotland Source: International Congress 2017 – Asthma management Year: 2017